Time since chemotherapy may predict response to olaparib in ovarian cancer 29 Jun 2017 Women with advanced ovarian cancer who begin treatment with olaparib are more likely to respond to the drug if it has been more than a year since their last round of chemotherapy, according to new research. Find out more Show/Hide